Puchelle E, Zahm J M, Aug F
Groupe d'étude des systèmes muco-ciliaires, INSERM U314, Reims.
Presse Med. 1988 Mar 19;17(10):479-84.
The mucociliary system represents the first respiratory tract barrier which acts by removing insoluble particles from the conductive airways. Impairment of mucociliary clearance, due to respiratory mucus and ciliary activity abnormalities, leads to mucus stasis, responsible for infection and bronchial obstruction. In obstructive airway diseases, the efficiency of the mucociliary function can be investigated quantitatively by in vivo and in vitro tests. In vivo mucociliary clearance can be measured by radioactive marker techniques. In vitro tests can evaluate the physical properties and transportability of mucus. The ciliary function can easily be analyzed on ciliated cells collected by nasal or bronchial brushing. Coupled with respiratory function tests, the investigation of the mucociliary function by in vivo and in vitro tests, provides a guideline for selection and assessment of drugs used to correct mucociliary disorders.
黏液纤毛系统是呼吸道的第一道屏障,其作用是清除传导气道中的不溶性颗粒。由于呼吸道黏液和纤毛活动异常导致的黏液纤毛清除功能受损,会导致黏液淤积,进而引发感染和支气管阻塞。在阻塞性气道疾病中,可以通过体内和体外试验定量研究黏液纤毛功能的效率。体内黏液纤毛清除功能可通过放射性标记技术进行测量。体外试验可评估黏液的物理特性和运输能力。通过鼻刷或支气管刷收集的纤毛细胞,可轻松分析纤毛功能。结合呼吸功能测试,通过体内和体外试验对黏液纤毛功能进行研究,可为纠正黏液纤毛紊乱所用药物的选择和评估提供指导。